Secrest Blakey & Associates’s Eli Lilly LLY Stock Holding History

Secrest Blakey & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$962K	Hold	6,500	–	–	2.2%	13
2020 Q2	$1.07M	Sell	6,500 -1,000	-13%	-$153K	2.57%	11
2020 Q1	$1.04M	Hold	7,500	–	–	2.83%	11
2019 Q4	$986K	Hold	7,500	–	–	2.17%	15
2019 Q3	$839K	Hold	7,500	–	–	0.69%	40
2019 Q2	$831K	Hold	7,500	–	–	0.72%	40
2019 Q1	$973K	Hold	7,500	–	–	0.95%	30
2018 Q4	$868K	Hold	7,500	–	–	0.73%	41
2018 Q3	$805K	Hold	7,500	–	–	0.62%	46
2018 Q2	$640K	Hold	7,500	–	–	0.5%	59
2018 Q1	$580K	Hold	7,500	–	–	0.5%	57
2017 Q4	$633K	Buy	+7,500	New	+$638K	0.51%	58

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Secrest Blakey & Associates's LLY Position: Q3 2020 in Review

Secrest Blakey & Associates held its Eli Lilly (LLY) position steady in Q3 2020 at 6,500 shares worth $962K. The position accounts for 2.2% of the portfolio, ranked #13.

Secrest Blakey & Associates first reported a position in LLY in Q4 2017 and has held it in 12 quarters since. The position peaked at $1.07M in Q2 2020. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

Secrest Blakey & Associates held 6,500 shares of Eli Lilly worth $962K as of Q3 2020.
Secrest Blakey & Associates left its Eli Lilly share count unchanged in Q3 2020.
Eli Lilly made up 2.2% of Secrest Blakey & Associates's portfolio in Q3 2020, its #13 holding.
Secrest Blakey & Associates first reported a position in Eli Lilly in Q4 2017 and has held it in 12 quarters since.
Secrest Blakey & Associates's Eli Lilly position peaked at $1.07M in Q2 2020.
1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.